Riskpilot← Back to searchSign inGet full accessAnatomia Marcus Eng AB
ABActiveOrg 5590830393Nackabyliden 14Physiotherapy activities · NACE 8695Est. 20161 employees
Revenue 2024
SEK 0
EBITDA margin
—
+53% vs 2023
Equity ratio
71.8%
Financial strength
Net profit 2024
SEK -33K
+52% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -33K | +53% |
| Net profit | SEK -33K | +52% |
| Total assets | SEK 355K | +23% |
| Equity | SEK 255K | -11% |
| Employees | 1 | — |
Legal name
Anatomia Marcus Eng AB
Org number
5590830393
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
1 november 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva fysioterapi samt konsultationer och utbildning inom hälso- och sjukvård samt därmed förenlig verksamhet.
Address
Nackabyliden 14
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 300 | 902 | 298 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 308 | 124 | −45 | −70 | −33 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 308 | 124 | −45 | −70 | −33 |
| Net financials | — | — | — | 1 | — |
| Profit before tax | 308 | 124 | −45 | −69 | −33 |
| Tax | −64 | −29 | −0 | −0 | −0 |
| Net profit | 244 | 95 | −45 | −69 | −33 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 689 | 458 | 358 | 288 | 355 |
| Equity | 608 | 453 | 357 | 288 | 255 |
| Long-term debt | 0 | 0 | 0 | 0 | 100 |
| Short-term debt | 81 | 5 | 1 | 0 | 0 |
| Total debt | 81 | 5 | 1 | — | 100 |
EBITDA margin
-3300000.0%
This company
15.8%
Market median
-20886176% vs market
20202024
Equity ratio
71.8%
This company
38.2%
Market median
+88% vs market
20202024
Return on equity
-12.9%
This company
18.4%
Market median
-170% vs market
20202024
Net profit margin
-3300000.0%
This company
8.1%
Market median
-40740841% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Anatomia Marcus Eng AB 
Anatomia Tech ABBoard members of Anatomia Marcus Eng AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Jenny Kristina Eng | Deputy Board Member | 0 companies |
| Carl Erik Marcus Eng | Board of Directors | 0 companies |